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Upon immunization and restimulation with tumors induced by the endogenous AKR/Gross murine leukemia
virus (MuLV), C57BL/6 mice generate vigorous H-2Kb-restricted cytotoxic T-lymphocyte (CTL) responses to a
determinant (KSPWFTTL) derived from the p15E transmembrane portion of the viral envelope glycoprotein.
By contrast, the highly homologous determinant RSPWFTTL, expressed by tumor cells induced by Friend/
Moloney/Rauscher (FMR) MuLV, is not immunogenic, even when presented to the immune system as vaccinia
virus-encoded cytosolic or endoplasmic reticulum (ER)-targeted minigene products. Such minigene products
are usually highly immunogenic since they bypass the need for cells to liberate the peptide or transport the
peptide into the ER by the transporter associated with antigen processing (TAP). Using KSPWFTTL-specific
CTLs that cross-react with RSPWFTTL, we previously demonstrated that presentation of RSPWFTTL from its
natural viral gene product is TAP dependent. Here, we show first that C57BL/6 mice express mRNA encoding
RSPWFTTL but not KSPWFTTL and second that the ER-targeted RSPWFTTL minigene product is highly
immunogenic in C57BL/6 mice with a targeted deletion in TAP1. These findings provide the initial demon-
stration of TAP-dependent tolerance induction to a specific self peptide and demonstrate that this contributes
to the differential recognition of RSPWFTTL and KSPWFTTL by C57BL/6 mice.
Major histocompatibility complex (MHC) class I-restricted
processing and presentation involve a series of coordinated
events resulting in the cell surface display of endogenously
synthesized viral or self peptides to cytotoxic T lymphocytes
(CTLs) (7). Cytosolic peptides, largely generated by protea-
somes, are shuttled into the lumen of the endoplasmic reticu-
lum (ER) by the transporter associated with antigen processing
(TAP), which is dedicated to this function. In the lumen of the
ER, MHC class I heavy chains loosely assemble with b2-mi-
croglobulin and acquire peptides transported from the cytosol.
General-purpose and dedicated molecular chaperones play im-
portant roles in facilitating the folding of nascent class I mol-
ecules and in forming a complex between class I molecules and
TAP (13, 22, 31). Class I molecules that acquire high-affinity
peptides form a highly stable complex that is rapidly trans-
ported from the ER to the cell surface for perusal by CTLs.
Viruses have evolved numerous mechanisms for evading
immune detection to persist in host cells. In the case of retro-
viruses, which exhibit extremely high mutation rates, sequence
variation can enable the virus to evade CTL-mediated destruc-
tion (6). In theory, such mutations can affect any of the steps
needed to generate immunogenic complexes: proteolytic liber-
ation, TAP transport, class I binding, or TcR recognition.
C57BL/6 mice (H-2b) have a low incidence of spontaneously
occurring thymic leukemias (relative to AKR mice [H-2k]) and
characteristically generate vigorous H-2Kb-restricted CTL re-
sponses directed against tumor cells induced by AKR/Gross
murine leukemia retroviruses (MuLV), the retroviruses that
are carried in the genome of AKR mice or derived by recom-
bination from these proviruses (8, 9, 12). Such CTLs (desig-
nated AKR/Gross MuLV-specific CTLs) predominantly rec-
ognize a determinant (KSPWFTTL) (10, 11, 27, 30) located
within the p15E transmembrane region of the viral envelope
protein. This determinant is present in nearly all endogenous
ecotropic MuLV examined (4) and several mink cell focus-
inducing (MCF) MuLV (3, 27).
AKR/Gross MuLV-specific CTLs are type-specific, efficient-
ly recognizing Gross cell surface antigen-expressing tumor cells,
but not Friend/Moloney/Rauscher (FMR) MuLV-induced tu-
mor cell lines (8, 12). Interestingly, FMR (and MCF13) MuLV
express the highly homologous determinant RSPWFTTL (which
differs only by a highly conserved K-to-R substitution in posi-
tion 1), yet FMR-induced tumors are very poorly recognized
by AKR/Gross MuLV-specific CTLs (8, 27). Previous studies
have demonstrated that the K-to-R substitution does not neg-
atively affect peptide binding to H-2Kb or the turnover rates of
peptide-stabilized cell surface H-2Kb complexes (17, 27). Nor
does the substitution affect the TAP-mediated transport of the
peptides into microsomes, although the P at position 3 greatly
hinders the transport of both peptides (20, 21). There is evi-
dence, however, that this substitution has a significant effect on
cleavage of the peptide (and extended versions) by purified 20S
proteasomes which cleave RSPWFTTL between R and S while
sparing the K-to-S junction (21). Based on the fragments gen-
erated from a 26-mer synthetic peptide precursor and the neg-
ative impact of P at position 3 on TAP-mediated transport, it
was proposed that KSPWFTTL was produced by proteasomes
as an intermediate with two or three NH2-terminal flanking
residues that were trimmed in the ER, while the presence of R
at position 1 prevents the generation of this precursor (21). In
support of this model, Sijts et al. reported that C57BL/6 mice
were capable of responding to synthetic RSPWFTTL peptide
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emulsified in incomplete Freund’s adjuvant (27), suggesting
that the poor immunogenicity of RSPWFTTL reflects a defect
in antigen presentation and not in the CTL repertoire.
Attempts by our laboratory to elicit RSPWFTTL-specific
CTLs, by immunizing C57BL/6 mice with synthetic RSPW
FTTL peptide emulsified in incomplete Freund’s adjuvant
(17), have been unsuccessful. Interestingly, the only CTL line
induced by the synthetic RSPWFTTL preparation proved to
recognize a minor contaminant present in the preparation. The
poor immunogenicity of RSPWFTTL was confirmed by ex-
pression as minigene cytosolic or ER-targeted gene products
expressed by recombinant vaccinia virus (rVV) or Sindbis virus
vectors that were used to immunize mice (4, 17).
Our findings suggested that limitations in the TcR repertoire
contribute to the poor immunogenicity of RSPWFTTL. Given
that C57BL/6 mice possess many proviruses in their genome,
perhaps including RSPWFTTL-encoding MuLV, it is plausible
that RSPWFTTL-specific CTLs are deleted or silenced by a
tolerance mechanism. In the present study we provide strong
support for this hypothesis.
The ability to elicit B6-derived secondary AKR/Gross
MuLV (KSPWFTTL; “peptide 12”)-specific CTLs, following
FIG. 1. C57BL/6 mice generate KSPWFTTL-specific, but not RSPWFTTL-specific, CTLs. C57BL/6 mice were immunized with 3 3 107 PFU of the indicated rVV
(intraperitoneally) and responding splenocytes stimulated in vitro with MC57 cells infected with various recombinant Sindbis viruses expressing either KSPWFTTL,
RSPWFTTL, or the negative control, chloramphenicol transferase (CAT). Spontaneous release values for MC57 target cells ranged from 7.9 to 13.4%. This experiment
was repeated two times with similar results.
FIG. 2. Confirmation of RSPWFTTL expression in lymphoid tissue by RT-PCR. Total mRNA was extracted from either spleen or thymic tissue from 6- to
8-week-old C57BL/6 or C57BL/6 TAP1-deficient mice for reverse transcription into cDNA and PCR amplification. The PCR products, generated by using cycling
conditions programmed at 95°C for 1 min, 55°C for 1 min, and 72°C for 2 min for 25 cycles, were verified for the predicted size by gel electrophoresis, purified, and
directly sequenced to confirm the presence of the correct TM134-141 sequences. RT-PCR utilizing the primers 623/7499 (GTACGGGATAGCATGGCCAAACTT
AGAGAA) and 623/7694 (CTACCGAAATCCTGTCTTTGATAAACTG), spanning the region encoding KSPWFTTL, could not detect the 225-bp PCR product
representative of KSPWFTTL mRNA expression (A). The primers p13B (AGATCCCCTTGGTTTACCACCTTG) and LTR3GEN (TACAGAAGCGAGAAGCG
AGC) (19), however, were able to detect the 662-bp PCR product representative of RSPWFTTL mRNA expression (B). The RT-PCRs were positively controlled by
including a reaction containing B6 genomic DNA isolated from the spleen. Lanes 2RT, conditions of cDNA synthesis where RT was not included; lanes 1RT, RT
was present. This experiment was performed two times, with similar results.
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in vivo priming with synthetic peptide or via a variety of en-
dogenous sources of KSPWFTTL, including rVV-driven mini-
gene expression, has been well documented (10, 11, 27, 30).
Our laboratory, however, has been unable to elicit RSPW
FTTL (“peptide 13”)-specific CTLs from B6 mice by these
approaches (4, 17) despite demonstrating the ability to im-
prove target cell surface presentation of RSPWFTTL in vitro
by targeting to the ER with signal-sequence (ss)-tagged mini-
gene constructs (Vac 13ss) (17). Figure 1 demonstrates that B6
mice immunized with Vac 12ss (expressing KSPWFTTL) could
easily generate secondary KSPWFTTL-specific CTLs when the
responding splenocytes were stimulated in vitro with MC57
cells infected with recombinant Sindbis virus expressing KSP
WFTTL (Sin 12; data not shown) (17) or KSPWFTTL coupled
to an ER-targeting sequence (Sin 12ss). When the same ap-
proach was adopted to obtain RSPWFTTL-specific CTLs,
however, by restimulation of splenocytes from B6 mice immu-
nized with Vac 13ss, RSPWFTTL-specific CTLs could not be
obtained. However, Vac 13ss targeting of the RSPWFTTL
epitope into the ER did allow for its cell surface presentation
on MC57 target cells in vitro, as demonstrated by the clear
susceptibility of MC57 cells to the cross-reactive recognition of
CTLs raised by secondary KSPWFTTL stimulation (Fig. 1), as
we have previously reported (17). The extent of lysis of ER-
targeted RSPWFTTL expressing target cells by KSPWFTTL-
specific CTLs is variable, but frequently is quite high, as shown
in Fig. 1.
To pursue the possibility that endogenously expressed RSP
WFTTL serves to tolerize RSPWFTTL-specific CD81 CTLs in
B6 mice, experiments were first designed to determine whether
the RSPWFTTL peptide is expressed in lymphoid tissues.
While B6 mice are known to contain multiple endogenous
proviruses in their genome, the expression of individual gene
products from proviral genomes in given tissues is not well
characterized. In Fig. 2, we examined lymphoid tissue, as self
antigens are known to be more tolerogenic when expressed by
lymphoid cells. To detect the expression of the RSPWFTTL-
containing viral peptide precursor, p15E (27, 30), reverse tran-
scriptase (RT)-PCR was performed on mRNA derived from
spleen and thymus. The PCR was positively controlled by in-
cluding extracted genomic DNA to detect the presence of
integrated proviral p15E and also included primers used in
separate reactions to amplify a ubiquitously expressed mes-
sage, b-actin, to control for differences in RNA extraction and
cDNA synthesis.
As depicted in Fig. 2, DNA sequences predicted to encode
either KSPWFTTL (Fig. 2A) or RSPWFTTL (Fig. 2B) were
readily detected in genomic DNA isolated from the spleens of
B6 mice. This is consistent with the presence of multiple en-
dogenous proviruses in all inbred mouse strains. Although a
KSPWFTTL DNA sequence was detected, we failed to detect
mRNA sequences encoding KSPWFTTL in either the spleen
or thymus (Fig. 2A). In contrast, RSPWFTTL-specific mRNA
was easily detected in these tissues from B6 mice (Fig. 2B). The
identity of this mRNA was confirmed by directly sequencing
the RT-PCR product (data not shown). These data demon-
strate that RSPWFTTL mRNA is expressed in B6 splenic and
thymic tissues, whereas KSPWFTTL mRNA is undetectable.
This is consistent with the contribution of tolerance to the
discrepancy between the immunogenicities of RSPWFTTL
and KSPWFTTL. To determine whether mutation of the tap1
gene had any effect on the expression of RSPWFTTL, mRNA
extracted from the spleen and thymus of B6 TAP1-deficient
mice (see experiments below) was also assessed. Again, mRNA
encoding RSPWFTTL was readily detected (Fig. 2B).
The presentation of RSPWFTTL (as well as KSPWFTTL) is
TAP dependent (17). Since TAP functions during thymic se-
lection, we reasoned that TAP12/2 mice would not present
RSPWFTTL and could respond to RSPWFTTL if such CTLs
were among those that are positively selected despite the ab-
sence of TAP1 (1, 25, 26). To enable the generation of RSP
WFTTL-Kb complexes in TAP-deficient antigen-presenting
cells (APCs), we primed mice with rVVs expressing ER-tar-
geted versions of KSPWFTTL (Vac 12ss) or RSPWFTTL (Vac
13ss). Two weeks following immunization, memory CTL activ-
ity was determined by in vitro restimulation with synthetic pep-
tides.
We initially examined (C57BL/6J 3 129/Sv)F2 TAP1-defi-
cient mice. Immunization with VV 13ss resulted in the gener-
ation of memory CTLs specific for RSPWFTTL as demon-
strated by their lysis of human T2.Kb transfectant target cells
infected with VV 13ss but not a control VV (Vac 65) (Fig. 3A).
In the same experiment, TAP11/1 (C57BL/6J 3 129/Sv)F1
mice failed to generate an RSPWFTTL-specific response, al-
though they were perfectly capable of responding to KSPWF
TTL (Fig. 3B and C). This pattern of results was confirmed in
two additional experiments, including the demonstration that
the control TAP11/1 F1 mice were able to generate AKR/
Gross MuLV-specific CTLs following secondary KSPWFTTL
stimulation, and these CTLs showed substantial cross-reactive
lysis of Vac 13ss-infected T2.Kb target cells, similar to the
results shown for B6 antiviral CTLs in Fig. 1. In short, only
TAP1-deficient mice immunized with Vac 13ss responded to
RSPWFTTL (Fig. 3A).
FIG. 3. RSPWFTTL-specifics CTLs can be induced in (C57BL/6J 3 129/
Sv)F2 TAP1-deficient mice. (C57BL/6J 3 129/Sv)F2 TAP1-deficient (A) and
(C57BL/6J 3 129/Sv)F1 (B) mice were immunized with rVV expressing RSPW
FTTL coupled to an ER-targeting sequence (Vac 13ss). Secondary stimulation of
responder splenocytes was conducted in vitro with synthetic RSPWFTTL.
(C57BL/6J 3 129/Sv)F1 (C) mice were alternatively immunized with rVV ex-
pressing KSPWFTTL coupled to an ER-targeting sequence (Vac 12ss). Second-
ary stimulation of responder splenocytes was conducted in vitro with synthetic
KSPWFTTL. Human T2.Kb transfectant target cells, which were used to de-
crease “background” CTL lysis of uninfected target cells (due to increased
recognition of class I molecules presenting self peptides as a result of the altered
thymic selection processes in TAP2/2 mice), were infected with either Vac 12ss,
Vac 13ss, or control Vac 65 at a multiplicity of infection of 10:1 4 h before the
addition of effector CTLs. Spontaneous release values for T2.Kb target cells
ranged from 13.9 to 15.2%. This experiment was conducted three times, with
similar results.
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These observations were confirmed in fully backcrossed
C57BL/6J TAP1-deficient mice. In this experiment, we addi-
tionally determined that memory in vitro RSPWFTTL pep-
tide-restimulated CTLs from Vac 13ss-infected TAP12/2 mice
lysed both target cells that were infected with Vac 13ss, but not
Vac ES-OVA257-264 (Fig. 4A), and targets pulsed with syn-
thetic RSPWFTTL, but not the ovalbumin-derived H-2Kb-re-
stricted SIINFEKL immunodominant epitope (Fig. 4C). Thus,
although these anti-RSPWFTTL/Kb CTLs were cross-reactive
for T2.Kb cells infected with Vac 12ss or pulsed with the KSP
WFTTL peptide (Fig. 4A and C), similar to the converse cross-
reactivity of anti-KSPWFTTL/Kb CTLs of B6 (Fig. 1) or
(C57BL/6 3 129/Sv)F1 TAP
1/1 origin as discussed above, the
CTLs raised against RSPWFTTL were not broadly reactive. As
expected from our previous studies (4, 17) and the data of Fig.
1 and 3, synthetic RSPWFTTL peptide-restimulated spleno-
cytes from normal C57BL/6 mice immunized with Vac 13ss
failed to generate CTLs that recognized Vac 13ss-infected
(Fig. 4B) or RSPWFTTL peptide-pulsed (Fig. 4D) targets.
We interpret these findings to mean that expression of type-
specific MuLV p15E in C57BL/6 mice results in the TAP-
dependent tolerance of CTLs specific for RSPWFTTL. We
believe that this is the first demonstration of TAP-dependent
tolerance to a defined self-determinant. Although we detected
mRNA encoding RSPWFTTL in the thymus of B6 and B6
TAP-deficient mice, we cannot be certain that deletion occurs
centrally and not in the periphery, as has apparently been
demonstrated following infection of adult C57BL/6 mice with
an exogenous MuLV expressing KSPWFTTL (5). It will be
possible, however, to address the question of central versus
peripheral tolerance in future experiments by thymic trans-
plantation.
The specificity of tolerance induction for CTL responses to
the RSPWFTTL variant of this retroviral epitope is somewhat
curious, if not paradoxical, given the observed reciprocal cross-
reactions observed for RSPWFTTL recognition by C57BL/6-
derived anti-KSPWFTTL CTLs (Fig. 1) (17) and recognition
of KSPWFTTL by anti-RSPWFTTL CTLs from C57BL/6
TAP1-deficient mice (Fig. 4). Our explanation is based on the
evidence that in wild-type C57BL/6 mice, RSPWFTTL from
endogenous sources is antigenic but not immunogenic, consis-
tent with functional tolerance of high-affinity or -avidity RSP
WFTTL-specific CTL clones. It is only in C57BL/6 TAP1-
deficient mice where these high-affinity or -avidity CTL clones
are not subject to tolerance induction and persist, allowing for
CTL responses to be raised against (endogenous) RSPWFTTL
stimulation. These RSPWFTTL-specific CTLs can also cross-
reactively recognize KSPWFTTL (Fig. 4), analogous to the
cross-reactive recognition of RSPWFTTL by anti-KSPWFTTL
CTLs (Fig. 1).
Regarding the originating source of RSPWFTTL, the only
reported ecotropic provirus in C57BL/6 mice is emv-2, which
has not been molecularly cloned or sequenced (15, 29). RSP
WFTTL may be present in the emv-2 envelope. Alternatively,
emv-2 sequences may contribute to the formation, in C57BL/6
mice, of other ecotropic or polytropic infectious recombinant
MuLV that express RSPWFTTL. For example, our laboratory
has reported that the BM5 ecotropic helper MuLV (i.e., from
the LP-BM5 retroviral complex that causes murine AIDS),
which originates from C57BL/6 mice, expresses the RSPWF
TTL epitope (4). Other endogenous MuLV may serve as a
source of expressed RSPWFTTL. Endogenous xenotropic
Bxv-1 MuLV, for example, is known to encode RSPWFTTL,
and its DNA is detectable in C57BL/6 mice (28). Since Bxv-1
does not infect murine cells due to its xenotropic host range,
Bxv-1 provides the donor sequences that encode RSPWFTTL,
such as in the recombinant MCF-13 MuLV that was previously
shown to be poorly recognized by KSPWFTTL-specific CTLs (3).
FIG. 4. RSPWFTTL-specific CTLs can be induced in C57BL/6 TAP1-deficient mice. C57BL/6J TAP1-deficient (A and C) and C57BL/6J (B and D) mice were
immunized with Vac 13ss. Secondary stimulations of responding splenocytes were conducted in vitro with synthetic RSPWFTTL, and CTL activity was assessed by
testing against T2.Kb targets infected with Vac 12ss, Vac 13ss, or Vac ES OVA257-264, as indicated in the legend to Fig. 3, before the addition of effector CTLs (A and
B). Alternatively, primed and restimulated splenocytes were tested against T2.Kb targets pulsed with either KSPWFTTL, RSPWFTTL, or SIINFEKL synthetic peptide
(C and D). Spontaneous release values for T2.Kb target cells ranged from 0.9 to 4.9%. This experiment was repeated two times, with similar results.
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In summary, we have provided strong evidence supporting a
TAP-dependent, specific tolerance mechanism as a basis for
nonresponsiveness to the RSPWFTTL variant epitope in
C57BL/6 mice. These findings do not exclude the possibility
that inefficient liberation of RSPWFTTL from p15E (21) limits
its antigenicity in RMA or other cell lines used as APCs in
vitro. Thus, in vivo tolerance induction leading to the inability
of B6 mice to generate high-affinity, RSPWFTTL-specific an-
tiviral CTLs to endogenous sources of this peptide, as dis-
cussed herein, is compatible with additional mechanistic de-
fects in the presentation of RSPWFTTL/Kb complexes for
CTL-mediated recognition. Indeed, using proteasome in vitro
reconstitution assays and/or following RSPWFTTL/Kb expres-
sion by use of cross-reactive CTLs raised to KSPWFTTL, ev-
idence has been provided not only for poor processing (21) but
also for relatively inefficient TAP-mediated transport (17) for
RSPWFTTL compared to that for KSPWFTTL. Our results
here do suggest, however, that generation of the RSPWFTTL
peptide in vivo is not limiting for inducing tolerance in a large
fraction of RSPWFTTL-specific CTLs.
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ADDENDUM IN PROOF
Regarding the MuLV source of the tolerizing RSPWFTTL-
encoding sequences, Li et al. (M. Li, X. Huang, Z. Zhu, and E.
Gorelik, J. Virol. 73:9178–9186, 1999) have recently sequenced
emv-2 and determined that the p15E envelope specifies the
KSPWFTTL version of the CTL epitope, thus suggesting that
RSPWFTTL expression originates from nonecotropic MuLV
sequences.
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